Comparative analysis of cellular immune responses and cytokine levels in sheep experimentally infected with bluetongue virus serotype 1 and 8

Veterinary Microbiology

Volumn 177, Issue 1-2, 2015, Pages 95-105

  Sanchez Cordon P J ^a   Perez de Diego A C ^b   Gomez Villamandos J C ^a   Sanchez Vizcaino J M ^b   Pleguezuelos, F J ^a   Garfia, B ^c   del Carmen, P ^b   Pedrera, M ^a,d  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c Garfia Veterinary Medicine Laboratory SL   (Spain)

^d INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Bluetongue virus serotypes 1 and 8; Cytokines; Immune response; Sheep

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BLUETONGUE ORBIVIRUS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; NONHUMAN; SEROTYPE; SHEEP; T LYMPHOCYTE SUBPOPULATION; VIREMIA; ANIMAL; BLUETONGUE; DOMESTIC SHEEP; HUMORAL IMMUNITY; IMMUNOLOGY; VIROLOGY;

BLUETONGUE VIRUS; OVIS ARIES;

ANIMALS; ANTIBODIES, NEUTRALIZING; BLUETONGUE; BLUETONGUE VIRUS; CYTOKINES; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKIN-4; SHEEP; SHEEP, DOMESTIC; TUMOR NECROSIS FACTOR-ALPHA; VIREMIA;

EID: 84926245766     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2015.02.022     Document Type: Article

References (37)

1. Askenasy N., Kaminitz A., Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun. Rev. 2008, 7:370-375.
2. Baldwin C.L., Sathiyaseelan T., Naiman B., White A.M., Brown R., Blumerman S., Rogers A., Black S.J. Activation of bovine peripheral blood gammadelta T cells for cell division and IFN-gamma production. Vet. Immunol. Immunopathol. 2002, 87:251-259.
3. Barratt-Boyes S.M., Rossitto P.V., Taylor B.C., Ellis J.A., MacLachlan N.J. Response of the regional lymph node to bluetongue virus infection in calves. Vet. Immunol. Immunopathol. 1995, 45:73-84.
4. Channappanavar R., Singh K.P., Singh R., Umeshappa C.S., Ingale S.L., Pandey A.B. Enhanced proinflammatory cytokine activity during experimental bluetongue virus-1 infection in Indian native sheep. Vet. Immunol. Immunopathol. 2012, 145:485-492.
5. Dahiya S., Prasad G., Kovi R.C. VP2 gene based phylogenetic relationship of Indian isolates of Bluetongue virus serotype 1 and other serotypes from different parts of the world. DNA Seq. 2004, 15:351-361.
6. Darpel K.E., Batten C.A., Veronesi E., Shaw A.E., Anthony S., Bachanek-Bankowska K., Kgosana L., Bin-Tarif A., Carpenter S., Müller-Doblies U.U., Takamatsu H.H., Mellor P.S., Mertens P.P.C., Oura C.A.L. Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet. Rec. 2007, 161:253-261.
7. DeMaula C.D., Leutenegger C.M., Jutila M.A., MacLachlan N.J. Bluetongue virus-induced activation of primary bovine lung microvascular endothelial cells. Vet. Immunol. Immunopathol. 2002, 86:147-157.
8. Gandini M., Reis S.R., Torrentes-Carvalho A., Azeredo E.L., Freire Mda S., Galler R., Kubelka C.F. Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles. Mem. Inst. Oswaldo Cruz 2011, 106:594-605.
9. Gilliet M., Liu Y.J. Generation of human CD8T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 2002, 195:695-704.
10. Hamblin C., Salt J.S., Graham S.D., Hopwood K., Wade-Evans A.M. Bluetongue virus serotypes 1 and 3 infection in Poll Dorset sheep. Aust. Vet. J. 1998, 76:622-629.
11. Hemati B., Contreras V., Urien C., Bonneau M., Takamatsu H.H., Mertens P.P., Bréard E., Sailleau C., Zientara S., Schwartz-Cornil I. Bluetongue virus targets conventional dendritic cells in skin lymph. J. Virol. 2009, 83:8789-8799.
12. Herbeuval J.P., Boasso A., Grivel J.C., Ardí A.W., Anderson S.A., Dolan M.J., Chougnet C., Lifson J.D., Shearer G.M. TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 2005, 105:2458-2464.
13. Jeggo M.H., Wardley R.C., Taylor W.P. Role of neutralising antibody in passive immunity to bluetongue infection. Vet. Res. Sci. 1984, 36:81-86.
14. Jeggo M.H., Wardley R.C., Brownlie J. A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques. Immunology 1984, 52:403-410.
15. MacLachlan N.J., Jagels G., Rossitto P.V., Moore P.F., Heidner H.W. The pathogenesis of experimental bluetongue virus infection of calves. Vet. Pathol. 1990, 27:223-229.
16. MacLachlan N.J., Crafford J.E., Vernau W., Gardner I.A., Goddard A., Guthrie A.J., Venter E.H. Experimental reproduction of severe bluetongue in sheep. Vet. Pathol. 2008, 45:310-315.
17. Maclachlan N.J., Mayo C.E. Potential strategies for control of bluetongue, a globally emerging, Culicoides-transmitted viral disease of ruminant livestock and wildlife. Antiviral Res. 2013, 99:79-90.
18. Maclachlan N.J., Henderson C., Schwartz-Cornil I., Zientara S. The immune response of ruminant livestock to bluetongue virus: from type I interferon to antibody. Virus Res. 2014, 182:71-77.
19. Malek T.R. T helper cells, IL-2 and the generation of cytotoxic T-cell responses. Trends Immunol. 2002, 23:465-467.
20. Mortola E., Larsen A. Bluetongue virus infection: signaling pathway activated during apoptosis. Rev. Argent. Microbiol. 2009, 41:134-140. (in Spanish, with English abstract).
21. Oura C.A., Wood J.L., Sanders A.J., Bin-Tarif A., Henstock M., Edwards L., Floyd T., Simmons H., Batten C.A. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. Vaccine 2009, 27:7326-7330.
22. Owens R.J., Limn C., Roy P. Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release. J. Virol. 2004, 78:6649-6656.
23. Pérez de Diego A.C., Sánchez-Cordón P.J., de las Heras A.I., Sánchez-Vizcaíno J.M. Characterization of the immune response induced by a commercially available inactivated bluetongue virus serotype 1 vaccine in sheep. Sci. World J. 2012, 2012:147158.
24. Roth K., Oehme L., Zehentmeier S., Zhang Y., Niesner R., Hauser A.E. Tracking plasma cell differentiation and survival. Cytometry A 2014, 85:15-24.
25. Rojas J.M., Rodríguez-Calvo T., Peña L., Sevilla N. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep. Vaccine 2011, 29:6848-6857.
26. Sánchez-Cordón P.J., Rodríguez-Sánchez B., Risalde M.A., Molina V., Pedrera M., Sánchez-Vizcaíno J.M., Gómez-Villamandos J.C. Immunohistochemical detection of bluetongue virus in fixed tissue. J. Comp. Pathol. 2010, 143:20-28.
27. Sánchez-Cordón P.J., Pedrera M., Risalde M.A., Molina V., Rodríguez-Sánchez B., Núñez A., Sánchez-Vizcaíno J.M., Gómez-Villamandos J.C. Potential role of proinflammatory cytokines in the pathogenetic mechanisms of vascular lesions in goats naturally infected with bluetongue virus serotype 1. Transbound. Emerg. Dis. 2013, 60:252-262.
28. Sánchez-Cordón P.J., Pleguezuelos F.J., Pérez de Diego A.C., Gómez-Villamandos J.C., Sánchez-Vizcaíno J.M., Cerón J.J., Tecles F., Garfia B., Pedrera M. Comparative study of clinical courses, gross lesions, acute phase response and coagulation disorders in sheep inoculated with bluetongue virus serotype 1 and 8. Vet. Microbiol. 2013, 166:184-194.
29. Savini G., Hamers C., Conte A., Migliaccio P., Bonfini B., Teodori L., Di Ventura M., Hudelet P., Schumacher C., Caporale V. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet. Microbiol. 2009, 133:1-8.
30. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96:41-101.
31. Takamatsu H., Mellor P.S., Mertens P.P., Kirkham P.A., Burroughs J.N., Parkhouse R.M. A possible overwintering mechanism for bluetongue virus in the absence of the insect vector. J. Gen. Virol. 2003, 84:227-235.
32. Thornton A.M., Shevach E.M. Suppressor effector function of CD4+ CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 2000, 164:183-190.
33. Trinchieri G., Kubin M., Bellone G., Cassatella M.A. Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. J. Cell. Biochem. 1993, 53:301-308.
34. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
35. Umeshappa C.S., Singh K.P., Nanjundappa R.H., Pandey A.B. Apoptosis and immuno-suppression in sheep infected with bluetongue virus serotype-23. Vet. Microbiol. 2010, 144:310-318.
36. Umeshappa C.S., Singh K.P., Pandey A.B., Singh R.P., Nanjundappa R.H. Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetonguevirus serotype-1 vaccine in sheep. Vaccine 2010, 28:2522-2531.
37. Van Miert A.S. Pro-inflammatory cytokines in a ruminant model: pathophysiological, pharmacological, and therapeutic aspects. Vet. Q. 1995, 17:41-50.